This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA
Menu
Key Sessions
Fouad Atouf
PLENARY KEYNOTE: Evolving Pharmacopeial Standards to Shape the Future of Biological Medicines
US Pharmacopeia
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right

Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
11:25am - 11:30am
Chairperson Remarks: Cell Line Development & Engineering
  • Landon Mott - Process Development Principal Scientist, Amgen Inc.
11:30am - 12:00pm
Removing remaining limitations for plant-based expression of biologicals and unlocking large-scale, commercial-grade cell culture potential
  • Andreas Schaaf - CSO & Managing Director, Eleva GmbH
12:00pm - 12:30pm
Enhancing production cell line development through a next-generation sequencing platform
  • Xiaodong Sun - Senior Scientist, Takeda
12:30pm - 1:00pm
New HT clone screening platforms predictable for bioreactor performance
  • Anke Mayer-Bartschmid - Senior Principal Scientist, Bayer Pharma
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson Remarks: Cell Line Development & Engineering
  • Landon Mott - Process Development Principal Scientist, Amgen Inc.
2:15pm - 2:45pm
13 C Metabolic Flux Analysis (MFA) of CHO cells utilizing various media and feed packages to elucidate metabolic bottlenecks
  • Lorena Pena - Scientist, Bristol-Myers Squibb
2:45pm - 3:15pm
Optimizing Vector Design to Enhance Expression and Quality of Bispecific Antibodies
  • Fernanda Sobreira - Associate Principal Scientist, Merck
3:15pm - 3:45pm
Advantages of AI + Site-specific Integration Cell Line Development (AlfaCell) in CMC Bioprocessing, Bi-specific Antibody and ADC Development
  • Michael Chen, PhD - CEO & Co-founder, Great Bay Bio
Showing 1 of 1 Streams
4:30pm - 5:00pm
A Comprehensive CHO Glycosylation Mutant Panel for Advancing Glycobiology and Therapeutic Protein Engineering
  • Song Zhiwei - Senior Principal Scientist, Nexa Biologics
5:00pm - 5:30pm
Accelerating Biopharmaceutical Cell Line Selection with Label-Free Multimodal Nonlinear Optical Microscopy and Machine Learning
  • Jindou Shi - PhD Student, GSK Center for Optical Molecular Imaging, UIUC
Tuesday 16th September - Main Conference Day One
NextThursday 18th September - Main Conference Day Three
Filter
Streams
Clear
Choose Day